Smoking and schizophrenia
暂无分享,去创建一个
[1] T. Schelling. Addictive drugs: the cigarette experience. , 1992, Science.
[2] J. Lohr. Oxygen radicals and neuropsychiatric illness. Some speculations. , 1991, Archives of general psychiatry.
[3] K. Fuxe,et al. Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the meso-diencephalic junction , 1991, Brain Research.
[4] M. Menza,et al. Smoking and movement disorders in psychiatric patients , 1991, Biological Psychiatry.
[5] P. Clarke,et al. Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. , 1990, Biochemical pharmacology.
[6] W. Coryell,et al. The influence of cigarette smoking on haloperidol pharmacokinetics , 1990, Biological Psychiatry.
[7] M. Allon,et al. Role of cigarette use in hyponatremia in schizophrenic patients. , 1990, The American journal of psychiatry.
[8] O. Wolkowitz,et al. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia. , 1990, Modern problems of pharmacopsychiatry.
[9] J. Herman,et al. Hypofrontality and cognitive impairment in schizophrenia: Dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function , 1990, Biological Psychiatry.
[10] D. Abrams,et al. Reasons for smoking and severity of residual nicotine withdrawal symptoms when using nicotine chewing gum. , 1989, British journal of addiction.
[11] G McKay,et al. Intersubject Variation in the Pharmacokinetics of Haloperidol and Reduced Haloperidol , 1989, Journal of clinical psychopharmacology.
[12] S. Mukherjee,et al. Serum antibodies to nicotinic acetylcholine receptors in schizophrenia , 1989, Biological Psychiatry.
[13] C. Prasad,et al. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density. , 1989, Biochemical and biophysical research communications.
[14] U. Ribary,et al. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. , 1989, The Journal of pharmacology and experimental therapeutics.
[15] T. Crow,et al. The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates , 1989, Psychological Medicine.
[16] A. Lajtha,et al. Action of nicotine on accumbens dopamine and attenuation with repeated administration. , 1989, European journal of pharmacology.
[17] R. Hamer,et al. Amphetamine Challenge Test, response to treatment, and lateral ventricle size in schizophrenia , 1989, Biological Psychiatry.
[18] Y. K. Fung. Effects of chronic nicotine pretreatment on (+)‐amphetamine and nicotine‐induced synthesis and release of [3H]dopamine from [3H]tyrosine in rat nucleus accumbens , 1989, The Journal of pharmacy and pharmacology.
[19] B. Wagner,et al. Does Smoking Reduce the Risk of Neuroleptic Parkinsonoids? , 1988, Pharmacopsychiatry.
[20] T. Roth,et al. Sleepiness and motor vehicle accidents. , 1988, International clinical psychopharmacology.
[21] G. Lunt,et al. Stereoselective Nicotine‐Induced Release of Dopamine from Striatal Synaptosomes: Concentration Dependence and Repetitive Stimulation , 1988, Journal of neurochemistry.
[22] H. Kazamatsuri,et al. Smoking and tardive dyskinesia , 1987, Biological Psychiatry.
[23] A. Lajtha,et al. Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease , 1987, Pharmacology Biochemistry and Behavior.
[24] R. Wyatt,et al. Calculating the Cost of Schizophrenia , 1987 .
[25] R. Shelton,et al. Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. , 1987, Clinical neuropharmacology.
[26] D. Weinberger. Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.
[27] N. Volkow,et al. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. , 1987, The American journal of psychiatry.
[28] S. Lal,et al. Nicotine exposure and tardive dyskinesia , 1987, Biological Psychiatry.
[29] G. Di Chiara,et al. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.
[30] J. Baron,et al. Cigarette smoking and Parkinson's disease , 1986, Neurology.
[31] G. Aston-Jones,et al. Nicotinic effects on the firing pattern of midbrain dopamine neurons. , 1986, Acta physiologica Scandinavica.
[32] J G Nutt,et al. A case‐control study of twin pairs discordant for Parkinson's disease , 1986, Neurology.
[33] D. Weinberger,et al. Polydipsia and chronic hyponatremia in schizophrenic inpatients. , 1985, The Journal of clinical psychiatry.
[34] Z. Cesarec,et al. Differential response to amphetamine in schizophrenia , 1985, Acta psychiatrica Scandinavica.
[35] A. Blum. The possible role of tobacco cigarette smoking in hyponatremia of long-term psychiatric patients. , 1984, JAMA.
[36] B. O'Shea,et al. Smoking and Malignancy in Schizophrenia , 1984, British Journal of Psychiatry.
[37] O. Vinař,et al. Smokers need higher doses of neuroleptic drugs. , 1984, Biological psychiatry.
[38] J. Lieberman,et al. ANTIBODIES TO ACETYLCHOLINE RECEPTORS IN TARDIVE DYSKINESIA , 1984, The Lancet.
[39] G. Stimmel,et al. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report. , 1983, The Journal of clinical psychiatry.
[40] R. Herning,et al. Smokers of low-yield cigarettes do not consume less nicotine. , 1983, The New England journal of medicine.
[41] C. Ward,et al. Parkinson's disease in 65 pairs of twins and in a set of quadruplets , 1983, Neurology.
[42] E. Melamed,et al. Stimulation of nigrostriatal dopamine neurones by nicotine , 1982, Neuropharmacology.
[43] R. Maurice-Williams,et al. Ruptured intracranial aneurysms: has the incidence of early rebleeding been over-estimated? , 1982, Journal of neurology, neurosurgery, and psychiatry.
[44] D. Jeste,et al. Understanding and Treating Tardive Dyskinesia , 1982 .
[45] R. Godwin-Austen,et al. Smoking and Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[46] A. Conney,et al. Cigarette smoking and chlorpromazine disposition and actions , 1982, Clinical pharmacology and therapeutics.
[47] T. Crow,et al. Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.
[48] A. Summerfield,et al. Orality and smoking. , 1979, British Journal of Medical Psychology.
[49] P. Costa,et al. Anxiety, extraversion and smoking. , 1978, The British journal of social and clinical psychology.
[50] M. Rawlins,et al. The Use of Event-Related Slow Potentials of the Brain in the Analysis of Effects of Cigarette Smoking and Nicotine in Humans , 1978 .
[51] D. Graham,et al. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.
[52] T. Crow,et al. MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA , 1978, The Lancet.
[53] J. Bland,et al. Academic performance and social factors related to cigarette smoking by schoolchildren. , 1977, British journal of preventive & social medicine.
[54] F. Hefti,et al. A quantitative correlation between single unit activity and fluorescence intensity of dopamine neurones in zona compacta of substantia nigra, as demonstrated under the influence of nicotine and physostigmine , 1976, Brain Research.
[55] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[56] P. Seeman,et al. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.
[57] M. Frankenhaeuser,et al. Immediate Effects of Cigarette Smoking as Related to Different Smoking Habits , 1975, Perceptual and motor skills.
[58] B. H. Fox,et al. Cancer risk among psychiatric patients: a hypothesis. , 1974, International journal of epidemiology.
[59] C. Swett. Drowsiness due to chlorpromazine in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program. , 1974, Archives of general psychiatry.
[60] A. F. Williams,et al. Personality and other characteristics associated with cigarette smoking among young teenagers. , 1973, Journal of health and social behavior.
[61] N. C. Rassidakis,et al. On the incidence of malignancy among schizophrenic patients. , 1973, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression.
[62] G. H. Hall,et al. Effects of nicotine on the release of 3 H-noradrenaline from the hypothalamus. , 1972, Biochemical pharmacology.
[63] E. Diamond,et al. Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis. , 1971, American journal of epidemiology.
[64] Clark Ms. Self-administered nicotine solutions preferred to placebo by the rat. , 1969, British journal of pharmacology.
[65] L. Stein,et al. Release of norepinephrine from hypothalamus and amygdala by rewarding medial forebrain bundle stimulation and amphetamine. , 1969, Journal of comparative and physiological psychology.
[66] J. Edwardson,et al. The effect of progesterone and some other agents on the failure of pregnancy produced by feeding agroclavine, an ergot alkaloid, in the rat. , 1969, British journal of pharmacology.
[67] M. Seevers. Psychopharmacological elements of drug dependence. , 1968, JAMA.
[68] G. H. Hall,et al. Further Evidence relating to the Mode of Action of Nicotine in the Central Nervous System , 1967, Nature.
[69] A. Hussar. LEADING CAUSES OF DEATH IN INSTITUTIONALIZED CHRONIC SCHIZOPHRENIC PATIENTS: A STUDY OF 1,275 AUTOPSY PROTOCOLS , 1966, The Journal of nervous and mental disease.
[70] M. A. Jacobs,et al. RELATIONSHIP OF ORAL FRUSTRATION FACTORS WITH HEAVY CIGARETTE SMOKING IN MALES , 1965, The Journal of nervous and mental disease.
[71] J. Olds. Hypothalamic substrates of reward. , 1962, Physiological reviews.
[72] H. Eysenck,et al. Smoking and Personality* , 1960, British medical journal.
[73] S. Kay,et al. Tobacco addiction as a marker of age at onset of schizophrenia. , 1991, The International journal of neuroscience.
[74] T. Svensson,et al. Effect of nicotine on dynamic function of brain catecholamine neurons. , 1990, Ciba Foundation symposium.
[75] M S Buchsbaum,et al. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. , 1990, Schizophrenia bulletin.
[76] T. Svensson,et al. Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo. , 1990, Pharmacology & toxicology.
[77] A. Drasdo,et al. Presynaptic nicotinic receptors and the modulation of transmitter release. , 1990, Ciba Foundation symposium.
[78] A. C. Collins,et al. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. , 1990, Ciba Foundation symposium.
[79] J R Hughes,et al. Prevalence of smoking among psychiatric outpatients. , 1986, The American journal of psychiatry.
[80] T. Crow,et al. The two-syndrome concept: origins and current status. , 1985, Schizophrenia bulletin.
[81] L. DeLisi,et al. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients. , 1985, The American journal of psychiatry.
[82] G. Cohen. Oxy-radical toxicity in catecholamine neurons. , 1984, Neurotoxicology.
[83] G. Connors,et al. Addictive behaviors among hospitalized psychiatric patients. , 1983, Addictive behaviors.
[84] H. Ashton,et al. Smoking: Psychology and Pharmacology , 1982 .
[85] H. Eysenck,et al. The causes and effects of smoking , 1980 .
[86] G. H. Hall. The pharmacology of tobacco smoking in relation to schizophrenia , 1980 .
[87] H. Eysenck. Personality and the maintenance of the smoking habit. , 1973 .